{
    "symbol": "BMY",
    "quarter": 3,
    "year": 2022,
    "date": "2022-10-26 13:02:09",
    "content": "  In terms of what we're seeing on the access side, our focus continues to be threefold on access: first, removing the market -- new-to-market blocks that face all new products in this space; second, taking advantage of where we have open access today, and remember, we estimate that about 10% of patients have open access at the initial stages of this launch; and then obviously, it's all about building volume during the early phases of the launch and then leveraging that volume."
}